Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 7 results
Author
Title
Type
Year
Filters:
First Letter Of Title
is
C
[Clear All Filters]
2018
Davies AH
,
Beltran H
,
Zoubeidi A
. 2018.
Cellular plasticity and the neuroendocrine phenotype in prostate cancer.
.
Nat Rev Urol.
Mateo J
,
Cheng HH
,
Beltran H
,
Dolling D
,
Xu W
,
Pritchard CC
,
Mossop H
,
Rescigno P
,
Perez-Lopez R
,
Sailer V
et al.
. 2018.
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
.
Eur Urol.
2015
Terry S
,
El-Sayed IY
,
Destouches D
,
Maillé P
,
Nicolaiew N
,
Ploussard G
,
Semprez F
,
Pimpie C
,
Beltran H
,
Londono-Vallejo A
et al.
. 2015.
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
.
Oncotarget. 6(14):11994-2008.
2013
Mosquera JM
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia . (1):1-10.
Terry S
,
Maillé P
,
Baaddi H
,
Kheuang L
,
Soyeux P
,
Nicolaiew N
,
Ceraline J
,
Firlej V
,
Beltran H
,
Allory Y
et al.
. 2013.
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
.
Neoplasia. 15(7):761-72.
2012
Beltran H
,
Tagawa ST
,
Park K
,
MacDonald T
,
Milowsky MI
,
Mosquera JM
,
Rubin MA
,
Nanus DM
. 2012.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
.
J Clin Oncol. 30(36):386-9.
Beltran H
,
Tagawa ST
,
Park K
,
Macdonald T
,
Milowsky MI
,
Mosquera JMiguel
,
Rubin MA
,
Nanus DM
. 2012.
Challenges in recognizing treatment-related neuroendocrine prostate cancer.
.
J Clin Oncol. 30(36):e386-9.